Catherine Alix-Panabières, Full Professor of Oncology at the Faculty of Medicine of the University of Montpellier, shared a post by International Symposium on Minimal Residual Cancer, adding:
“Welcome to Prof Howard I. Scher at the ISMRC 2025 in Nice. Amazing to have him on board. An expert on Liquid Biopsy and Prostate Cancer.”
Quoting International Symposium on Minimal Residual Cancer‘s post:
“Howard I. Scher, MD, FASCO, has been at the forefront of prostate cancer research, advancing targeted therapies and the use of circulating tumor cells to guide treatment and accelerate drug development. At ISMRC2025, he’ll share insights on integrating liquid biopsies into clinical practice and regulatory science.
Register now. The ISMRC2025 is organized by Paul Hofman, Catherine Alix-Panabières and Klaus Pantel.”